The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2
Open accessAbstract
Genes mutated in patients with Fanconi anemia (FA) interact with the DNA repair genes BRCA1 and BRCA2/FANCD1 to suppress tumorigenesis, but the molecular functions ascribed to them cannot fully explain all of their cellular roles. Here, we show a repair-independent requirement for FA genes, including FANCD2, and BRCA1 in protecting stalled replication forks from degradation. Fork protection is surprisingly rescued in FANCD2-deficient cells by elevated RAD51 levels or stabilized RAD51 filaments. Moreover, FANCD2-mediated fork protection is epistatic with RAD51 functions, revealing an unanticipated fork protection pathway that connects FA genes to RAD51 and the BRCA1/2 breast cancer suppressors. Collective results imply a unified molecular mechanism for repair-independent functions of FA, RAD51, and BRCA1/2 proteins in preventing genomic instability and suppressing tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BRCA1 is implicated in a repair-independent mechanism in protecting stalled replication forks from degradation to maintain genome stability (Schlacher et al., 2012).”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
In the citing paper
“As previously shown, BRCA1-deficient cells show significant shortening of fork length following hydroxyurea (HU) treatment indicating degradation of stalled replication forks.”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
In the citing paper
“In addition, Abraxas did not appear to be required for efficient replication restart after HU treatment (data not shown), consistent with published observation that BRCA1 is not required for replication recovery (Schlacher et al., 2012).”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Schlacher, K., Christ, N., Siaud, N., Egashira, A., Wu, H., & Jasin, M. (2011) · Cell · doi:10.1016/j.cell.2011.03.041 · Cited by 1,292
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Self-citationInteraction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Nucleotide deficiency promotes genomic instability in early stages of cancer development
Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., & Kerem, B. (2011) · Cell · doi:10.1016/j.cell.2011.03.044 · Cited by 858
Advanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791
Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G. E., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80276-2 · Cited by 635
How the Fanconi Anemia Pathway Guards the Genome
Moldovan, G., & D’Andrea, A. D. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134222 · Cited by 601
Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis
Hashimoto, Y., Chaudhuri, A. R., Lopes, M., & Costanzo, V. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1927 · Cited by 537
The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair
Knipscheer, P., Räschle, M., Smogorzewska, A., Enoiu, M., Ho, T. V., Schärer, O. D., Elledge, S. J., & Walter, J. C. (2009) · Science · doi:10.1126/science.1182372 · Cited by 525
Research works printed but not linked: 1
- Schroeder, 1964, [Spontaneous chromosome aberrations in familial panmyelopathy], Humangenetik, 1, 194
Cited by
Sorted by citations
Items 701–800 of 930
More end resection is not merrier
Zong, D., Chaudhuri, A. R., & Nussenzweig, A. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3274 · Cited by 8
Distinct roles of RECQL5 in RAD51-mediated fork reversal and transcription elongation
Nagraj, T., Sahoo, S., Kadupatil, S., & Nagaraju, G. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1019 · Cited by 6
Haanpää, M. K. (2014) · Cited by 6
The ORFIUS complex regulates ORC2 localization at replication origins
Yang, Z., Mogre, S., He, R., Berdan, E. L., Sui, S. J. H., & Hill, S. J. (2024) · NAR Cancer · doi:10.1093/narcan/zcae003 · Cited by 6
Takahashi, J., Masuda, T., Kitagawa, A., Tobo, T., Nakano, Y., Abe, T., Ando, Y., Kosai, K., Kobayashi, Y., Matsumoto, Y., et al. (2021) · Oncology · doi:10.1159/000520582 · Cited by 6
Handwerk, L., Schreier, H. K., Kraft, D., Shreder, K., Hemmersbach, R., Hauslage, J., Bonig, H. B., Wiesmüller, L., Fournier, C., & Rall-Scharpf, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813761 · Cited by 6
SMC5/6 Promotes Replication Fork Stability via Negative Regulation of the COP9 Signalosome
Xu, M. J., & Jordan, P. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020952 · Cited by 6
Transcriptional Regulation of Emergency Granulopoiesis in Leukemia
Hasan, S., Naqvi, A. R., & Rizvi, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00481 · Cited by 6
In Vitro Reconstitution of BRCA1-BARD1/RAD51-Mediated Homologous DNA Pairing
Wang, M., Rogers, C. M., Alimbetov, D. S., & Zhao, W. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2063-2_13 · Cited by 6
Bose, M., Sachsenweger, J., Laurila, N., Parplys, A. C., Willmann, J., Jungwirth, J., Groth, M., Rapakko, K., Nieminen, P. A., Friedl, T. W. P., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz252 · Cited by 6
Coregulation of FANCA and BRCA1 in human cells
Haitjema, A., Mol, B. M., Kooi, I. E., Massink, M. P. G., Jørgensen, J. A., Rockx, D., Rooimans, M. A., de Winter, J. P., Meijers-Heijboer, H. E. J., Joenje, H., et al. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-381 · Cited by 7
The nucleolar protein GNL3 prevents resection of stalled replication forks
Lebdy, R., Canut, M., Patouillard, J., Cadoret, J., Letessier, A., Ammar, J., Basbous, J., Urbach, S., Miotto, B., Constantinou, A., et al. (2023) · The EMBO Reports · doi:10.15252/embr.202357585 · Cited by 6
Chiou, L. F., Droby, G. N., Jayaprakash, D., Anand, J. R., Zhang, X., Yang, Y., Mills, C. A., Webb, T. S., Barker, N. K., Xie, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62368-8 · Cited by 5
Decoding replication stress responses through post-translational modifications
Han, J., Wu, M., Liu, T., & Huang, J. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-02023-x · Cited by 5
RAD51 separation of function mutation disables replication fork maintenance but preserves DSB repair
Son, M. Y., Beláň, O., Špı́rek, M., Cibulka, J., Nikulenkov, F., Kim, Y. Y., Hwang, S., Myung, K., Montagna, C., Kim, T. M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109524 · Cited by 5
Zaman, N., Kushwah, A. S., Badriprasad, A., & Chakraborty, G. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.03.004 · Cited by 5
The interferon response at the intersection of genome integrity and innate immunity
Duzanic, F. D., & Penengo, L. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103786 · Cited by 5
Kharat, S. S., Mishra, A. P., Sengodan, S. K., Dierman, D., Fox, S. D., Chazin, W., & Sharan, S. K. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110393 · Cited by 6
S-phase checkpoint protects from aberrant replication fork processing and degradation
Núñez-Martín, I., Drury, L. S., Martínez-Jiménez, M. I., Blanco, L., Diffley, J. F. X., Aguilera, A., & Gómez‐González, B. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf707 · Cited by 5
Novel targets for ATM-deficient malignancies
Winkler, J., Hofmann, K., & Chen, S. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29905 · Cited by 5
Fanconi anemia signaling and Mus81 cooperate to safeguard development and crosslink repair
Larin, M., Gallo, D., Tamblyn, L., Yang, J., Liao, H., Sabat, N., Brown, G. W., & McPherson, J. P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku676 · Cited by 5
Wang, Z., Chen, N., Yang, J. M., Wang, Q., & Li, A. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.86063 · Cited by 5
Proteolytic control of genome integrity at the replication fork
Rageul, J., Weinheimer, A. S., Park, J. J., & Kim, H. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102657 · Cited by 5
Application of Multilayer Evidence for Annotation of C-Terminal BRCA2 Variants
Butz, H., Papp, J., Bozsik, A., Krokker, L., Pócza, T., Oláh, E., & Patócs, A. (2021) · Cancers · doi:10.3390/cancers13040881 · Cited by 5
USP7 Deregulation Impairs S Phase Specific DNA Repair after Irradiation in Breast Cancer Cells
Vogt, M., Classen, S., Krause, A. K., Peter, N.-J., Petersen, C., Rothkamm, K., Borgmann, K., & Meyer, F. B. (2024) · Biomedicines · doi:10.3390/biomedicines12040762 · Cited by 4
Witham, M., & Hengel, S. R. (2024) · NAR Molecular Medicine · doi:10.1093/narmme/ugae010 · Cited by 6
Synergistic protection of nascent DNA at stalled forks by MSANTD4 and BRCA1/2–RAD51
Xie, H., Song, L., Mao, G., Han, J., Pu, J., Wu, Z., Chen, J., Zhou, J., Huang, J., Dong, F., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-024-01833-9 · Cited by 4
Replication stress responses in human lymphocytes change sex-specifically during aging
Rall-Scharpf, M., Schlotter, D., Koch, P., Szafranski, K., Groth, M., Sahm, A., Biber, S., Castaño, B. A., Heitmeir, B., Zengerling, F., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf498 · Cited by 4
Anagho, H. A., Mullari, M., Mattanovich, M., Cho, H., Pedersen, A.-K., Palasca, O., Olsen, J. V., Locard‐Paulet, M., & Nielsen, M. L. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101034 · Cited by 5
Ubiquitin and SUMO pathways in DNA replication and replication-coupled repair
Fiedorowicz, L., Baxley, R. M., Hendrickson, E. A., & Bielinsky, A. (2025) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2025.2574638 · Cited by 4
HSP90 buffers deleterious genetic variations in BRCA1
Gracia, B., Zhang, X.-H., Montes, P., Pham, T. C., Huang, M., Chen, J., & Karras, G. I. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.10.026 · Cited by 4
Barreto-Galvez, A., Niljikar, M., Gagliardi, J. E., Guzman, C. P., Zhang, R., Kumar, V., Juwarwala, A., Pradeep, A., Saxena, A., Montagna, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67171-z · Cited by 4
Bæk, S. Ø., Keuper, K., Milletti, G., Adelantado-Rubio, A., Lisby, M., Bartek, J. J., Dinant, C., & Maya‐Mendoza, A. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103914 · Cited by 4
BRCA2-dependent maturation of nascent strands during DNA replication
Milano, L., Wells, S. E., Vaitsiankova, A., Drummond‐Clarke, L., Zhu, X., Carreira, A., Kanemaki, M. T., & Caldecott, K. W. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.03.012 · Cited by 4
Cellular regulation and stability of DNA replication forks in eukaryotic cells
Li, X., Wang, L., Liu, X., Zheng, Z., & Kong, D. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103418 · Cited by 4
Mechanisms of PARP Inhibitor Resistance
O’Connor, M. J., & Forment, J. V. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-30065-3_3 · Cited by 4
Mashayekhi, F., Ganje, C., Caron, M., Heyza, J. R., Gao, Y., Zeinali, E., Fanta, M., Li, L., Ali, J. Y. H., Mersaoui, S. Y., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115066 · Cited by 4
Dyankova-Danovska, T., Uzunova, S., Danovski, G., Stamatov, R., Kanev, P.-B., Atemin, A., Ivanova, A., Aleksandrov, R., & Stoynov, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020667 · Cited by 4
Fanconi anemia and mTOR pathways functionally interact during stalled replication fork recovery
Nolan, M., Knudson, K., Holz, M. K., & Chaudhury, I. (2021) · FEBS Letters · doi:10.1002/1873-3468.14035 · Cited by 4
Brca1 Mouse Models: Functional Insights and Therapeutic Opportunities
Yueh, W.-T., Glass, D. J., & Johnson, N. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168372 · Cited by 4
Mohamed, T. M., Adolph, M. B., & Cortez, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101672 · Cited by 4
Courcelle, J., Worley, T. K., & Courcelle, C. T. (2022) · Genes · doi:10.3390/genes13030437 · Cited by 4
Lodovichi, S., Bellè, F., Mercatanti, A., Spugnesi, L., Cozzani, C., Caligo, M. A., Cervelli, T., & Galli, A. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac021 · Cited by 4
Thwarting endogenous stress: BRCA protects against aldehyde toxicity
Chaudhuri, A. R., & Nussenzweig, A. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201708194 · Cited by 5
Huang, Z., Feng, Y.-L., Liu, Q., Chen, R.-D., Liu, S., Wang, M., & Xie, A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf729 · Cited by 3
Cytosolic DNA and intracellular Ca2+: Maintaining genome stability during replication stress
Li, S., Lu, H.-T., & You, Z. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103877 · Cited by 3
Ortega, R., Taylor, E. R., Whitehead, S., Danhorn, T., Bitler, B. G., & Arnoult, N. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1437 · Cited by 4
Wang, Y., Nie, W.-Z., Lu, F.-Z., Liu, J.-Y., He, J.-H., Li, Y.-M., Li, X.-T., & Shen, Q. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109546 · Cited by 3
Yu, G., Xiong, Y., Xu, Z., Zhang, L., Zhou, X. A., Nie, C., Li, S., Wang, W., Li, X., & Wang, J. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00685-0 · Cited by 3
PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes
Yu, T., & Lok, B. H. (2024) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2024.2398494 · Cited by 3
Inhibition of DEK restores hematopoietic stem cell function in Fanconi anemia
Chen, Z., Wu, F., Li, Y., Li, L., Lei, Y., Gao, S., Chen, T., Xie, Y., Xiao, J., Zeng, H., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20241248 · Cited by 3
The emergence of a unified mechanism in the Fanconi anemia pathway
Xu, X., Guo, R., & Xu, D. (2021) · Genome Instability & Disease · doi:10.1007/s42764-021-00053-y · Cited by 3
BRCA2 Haploinsufficiency in Telomere Maintenance
Gunnarsdottir, S. R., Bjarnason, H., Þorvaldsdóttir, B., Paland, F., Steinarsdóttir, M., Eyfjord, J. E., & Böðvarsdóttir, S. K. (2021) · Genes · doi:10.3390/genes13010083 · Cited by 4
Yang, Z., Lemacon, D. S., Li, S., Cheruiyot, A., Kong, L., Tan, K., Chen, C., Turkay, E., He, D., & You, Z. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102215 · Cited by 3
Defining a genotoxic profile with mouse embryonic stem cells
Kim, T. M., Rebel, V. I., & Hasty, P. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213480700 · Cited by 3
BRCA1 loses the ring but lords over resistance
Powell, S. N. (2016) · Journal of Clinical Investigation · doi:10.1172/jci89209 · Cited by 3
Dynamic structures in DNA damage responses & cancer
Tainer, J. A. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.04.003 · Cited by 3
Role of PARylation and PTEN Mutation on PARP and PARG Inhibitor Efficacy on GlioblastomaPreprint
Hermanowski, H. M., Huebert, B., Aldrighetti, C. M., Hurley, J. K., & Quénet, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.30.180216 · Cited by 3
H2BK120ub and its reader RNF169 sequentially regulate replication fork remodeling and stability
Duzanic, F. D., Mohana-Natarajan, V., Fisicaro, S., Bakker, C., Aouami, M., Amaral, G., Lopes, M., Taneja, N., & Penengo, L. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00602-1 · Cited by 2
Loss of Fanconi anemia proteins causes a reliance on lysosomal exocytosis
Fu, B. X. H., Xu, A., Li, H., Johnson, D. E., Grandis, J. R., & Gilbert, L. A. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08164-0 · Cited by 2
Arachchi, R. Y. B., Okafor, D. C., Snyder, A. J., & Trakselis, M. A. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103909 · Cited by 2
Jansche, R., Heitmeir, B., Faust, U., Pospiech, H., Sutter, C., Albig, C., Hennig, F., Janni, W., Schmutzler, R., Hauke, J., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08463-0 · Cited by 2
Roy, S., Fimreite, M. M., Chen, Y., Citron, F., Draetta, G. F., & Schlacher, K. (2026) · Nature Communications · doi:10.1038/s41467-026-70716-5 · Cited by 2
Self-citationPARP Inhibition in Prostate Cancer: Current Status, Resistance Mechanisms, and Clinical Challenges
Matsuoka, T., Akamatsu, S., Ong, C. J., Gleave, M. E., & Wang, Y. (2026) · Cells · doi:10.3390/cells15070588 · Cited by 3
Taglialatela, A., & Ciccia, A. (2026) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-030222-114544 · Cited by 3
DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
Citron, F., Cecchetto, L., Granato, E., Ho, I.-L., Liu, Z., Balestrieri, C., Yen, E.-Y., Perelli, L., Zhang, L., Castillo, L. A., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-3849 · Cited by 2
Self-citationPhuong, D. J., Ralston, C. Q., Ezzat, T., Ashe, C. S., Armstrong, A. P., Flesken‐Nikitin, A., Yamulla, R. J., Nikitin, A. Y., & Schimenti, J. C. (2026) · Genetics · doi:10.1093/genetics/iyag098 · Cited by 2
The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells
Datta, A., Jackson, J., Morozov, Y. I., Qiu, J., Vindigni, A., & Greenberg, R. A. (2026) · Nature Communications · doi:10.1038/s41467-026-75271-7 · Cited by 2
Synthetic Lethality – Its Current Application and Potential in Oncological Treatment
Bortlíková, L., Müller, P., Vojtěšek, B., Rak, V., & Svoboda, M. (2019) · Klinicka onkologie · doi:10.14735/amko20193s19 · Cited by 2
Simo‐Cheyou, E. R., Boni, J., Boulais, J., Carpio, E. P., Malina, A., Sherill-Rofe, D., Luo, V. M., Gonçalves, C., Bagci, H., Maters, A., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010495 · Cited by 2
FANCD2 counteracts O6-methylguanine-induced mismatch repair-dependent apoptosis
Morita, S., Fujikane, R., Uechi, Y., Matsuura, T., & Hidaka, M. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09682-4 · Cited by 2
Single Molecular Resolution to Monitor DNA Replication Fork Dynamics upon Stress by DNA Fiber Assay
Liu, W. (2021) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4269 · Cited by 2
Nie, P., Zhang, C., Wu, F., Chen, S., & Wang, L. (2024) · Advanced Science · doi:10.1002/advs.202307751 · Cited by 2
Talens, F., Teixeira, V., Kok, Y. P., Chen, M., Rosenberg, E. H., Debipersad, R. D., Duiker, E. W., van den Tempel, N., Janatová, M., Zemánková, P., et al. (2024) · NAR Cancer · doi:10.1093/narcan/zcae044 · Cited by 2
Tang, M., Li, S., Zhu, Z., Wang, C., Ding, S., Zhang, H., Huang, M., Keast, S., Chen, Z., Yin, L., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf544 · Cited by 2
Keahi, D., Sanders, M. A., Paul, M. R., Webster, A., Fang, Y., Wiley, T. F., Shalaby, S., Carroll, T. S., Chandrasekharappa, S. C., Sandoval-Garcia, C., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2503872122 · Cited by 2
Perspectives on gene therapy for Fanconi anemia
Navarro, S., Rı́o, P., & Bueren, J. A. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1062752 · Cited by 2
A route to new cancer therapies: the FA pathway is essential in BRCA1- or BRCA2-deficient cells
Lachaud, C., & Rouse, J. W. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3276 · Cited by 3
Pharmacological Basis of Breast Cancer Resistance to Therapies - An Overview
Crucitta, S., Cucchiara, F., Sciandra, F., Cerbioni, A., Diodati, L., Rafaniello, C., Capuano, A., Fontana, A., Fogli, S., Danesi, R., et al. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210804100547 · Cited by 2
The Fanconi Anemia Pathway and Interstrand Cross-Link Repair
Ishiai, M., Tomida, J., Itaya, A., Hejna, J., & Takata, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55873-6_8 · Cited by 2
Brandsma, I., Sato, K., van Rossum-Fikkert, S. E., Reuter, M., Odijk, H., Verkaik, N. S., van den Tempel, N., Oostra, A. B., Dekkers, D. H. W., Bezstarosti, K., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/438945 · Cited by 2
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumoursPreprint
Dibitetto, D., Liptay, M., Vivalda, F., Gogola, E., Dogan, H., Fernández, M. G., Duarte, A. A., Schmid, J. A., Durant, S. T., Forment, J. V., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.22.541781 · Cited by 2
Chiou, L. F., Jayaprakash, D., Droby, G. N., Zhang, X., Yang, Y., Mills, C. A., Webb, T. S., Barker, N. K., Wu, D., Herring, L. E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.09.632184 · Cited by 2
Quantitative AI-based DNA fiber workflow to study replication stressPreprint
Fagherazzi, P., Diekmann, T., Ardizzoia, A., Machacova, Z., Negi, S., Yadav, A. K., Moudrý, P., Costanzo, V., & Polášek-Sedláčková, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.27.645743 · Cited by 2
Molecular Mechanisms of Early Breast Cancer
Ariyannur, P. S., & Srinivasalu, V. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-6171-9_5 · Cited by 1
Ohta, T., & Wu, W. (2021) · Springer eBooks · doi:10.1007/978-981-16-4521-1_2 · Cited by 1
Òdena, A., Monserrat, L., Brasó‐Maristany, F., García‐Galea, E., Casals, E., Molina, C., Herencia-Ropero, A., Pedretti, F., Domènech, H., Guzmán, M., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01172-5 · Cited by 1
Insights from three decades of BRCA1/2 modeling in mice
Darnold, J.-S., & Jonkers, J. (2026) · Nature Genetics · doi:10.1038/s41588-025-02448-z · Cited by 1
Dunbayev, Y., Chen, Y., Sassi, L., Lee, E. A., Ra, J. S., Choi, M., Mukherjee, A., Vásquez, K. M., Costanzo, V., Chi, P., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag332 · Cited by 1
Potent and isoform-selective PARP1 degraders for the treatment of BRCA-deficient cancers
Sun, H., Hu, Y., Jiayu, X. U. E., Guo, R., Liang, Y., Li, B., Xu, X., & Ren, J. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110204 · Cited by 1
Cai, Y., Chen, Z., Xiong, J., Zhao, Y., & Zhou, J. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189666 · Cited by 1
Liu, S., Shinohara, A., & Furukohri, A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105424 · Cited by 1
Li, J., Meng, Y., Ouyang, X., Lin, X., Wu, Y., & Kwok, H. F. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2025.159 · Cited by 1
The nuclease EXO1 promotes genomic instability by degrading nascent DNA in BRCA-proficient cells
Nusawardhana, A., Nicolae, C. M., & Moldovan, G. (2026) · Nature Communications · doi:10.1038/s41467-026-69981-1 · Cited by 1
EEPD1 evolved a unique DNA clamping dimer protecting reversed replication forks
Shen, R., Sarker, A. H., Chen, Y., Liu, M., Roy, S., Arvai, A. S., Bacolla, A., Ahmed, Z., Katsonis, P., Hammel, M., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag188 · Cited by 1
Self-citationVanderVere-Carozza, P. S., Jordan, M. R., Garrett, J., Pollok, K. E., Pawelczak, K. S., & Turchi, J. J. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag396 · Cited by 1
Bending Forks and Wagging Dogs—It’s about the DNA 3′ Tail
Tsutakawa, S. E., & Tainer, J. A. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.005 · Cited by 1
Conserved and divergent features of DNA repair. Future perspectives in genome stability research
Kovalchuk, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00037-4 · Cited by 1
Single-Cell Analysis of Histone Acetylation Dynamics at Replication Forks Using PLA and SIRF
Lee, S. Y., Kim, J. J., & Miller, K. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2788-4_23 · Cited by 1
The FANCA to FANCZ of DNA interstrand crosslink repair: Lessons from Fanconi anemia
O’Rourke, J. J., & Deans, A. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803582-5.00012-7 · Cited by 1
Metadata
- Authors
- Schlacher, K., Wu, H., & Jasin, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California, Los Angeles (US)
- Corresponding author
- Schlacher, Katharina
- Jasin, Maria
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 22
- Issue
- 1
- Pages
- 106-116
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3954744
- OpenAlex
- W2096380982
- Cited by
- 936
- References
- 46
- Citations by year
- 2026: 40 · 2025: 56 · 2024: 80 · 2023: 70 · 2022: 69 · 2021: 91 · 2020: 86 · 2019: 63 · 2018: 83 · 2017: 74 · 2016: 87 · 2015: 53 · 2014: 50 · 2013: 27 · 2012: 7
- FWCI
- 17.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA121110, P01-CA94060, P01CA094060)
- National Institute of General Medical Sciences (R01 GM54668, R01GM054668)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- Fanconi anemia, replication fork protection, FANCD2, RAD51, BRCA1, BRCA2, DNA repair, epistasis, genomic instability, tumor suppression
- MeSH terms
- Cell Line, Transformed, DNA Replication, Fanconi Anemia, Humans, Genes, BRCA1, Genes, BRCA2, BRCA2 Protein, Genomic Instability, Rad51 Recombinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review